Trial Profile
Adherence and patients' experiences with the use of capecitabine in cancer treatment: The exploration of factors affecting the use in daily practice.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 May 2013
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary)
- Indications Cancer
- Focus Therapeutic Use
- Acronyms Caper
- 27 May 2010 New trial record